In the last 12 months, insiders at TScan Therapeutics, Inc. ($TCRX) filed 53 transactions with the SEC: 15 open-market purchases totaling $3,724,537 and 1 sales totaling $952,116. Net insider sentiment: net buying.
TScan Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Lynx1 Capital Management LP (TenPercentOwner) — 10 transactions totaling $3,641,973
- ZDRAVESKI ZORAN (See Remarks) — 12 transactions totaling $1,483,636
- Klencke Barbara (Not found) — 5 transactions totaling $82,550
- BAKER BROS. ADVISORS LP (Not found) — 6 transactions totaling $14
- Dworak Leiden (See Remarks) — 1 transaction totaling $0
View all SEC Filings for TScan Therapeutics, Inc. (TCRX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2026 | Amello Jason | Chief Financial Officer | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 129,835,938 | 9999.99% | 0.27% |
| Jan. 20, 2026 | ZDRAVESKI ZORAN | See Remarks | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 129,835,938 | 9999.99% | 0.27% |
| Jan. 20, 2026 | Louis Chrystal | Chief Medical Officer | A | Stock Option (Right to Buy) | 420000 | $0.00 | 420,000.0000 | 129,835,938 | 9999.99% | 0.32% |
| Jan. 20, 2026 | Dworak Leiden | See Remarks | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 129,835,938 | 9999.99% | 0.08% |
| Jan. 20, 2026 | MacBeath Gavin | Chief Executive Officer | A | Stock Option (Right to Buy) | 1165000 | $0.00 | 1,165,000.0000 | 129,835,938 | 9999.99% | 0.90% |
| Dec. 22, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 75500 | $0.90 | 8,012,916.0000 | 129,835,938 | 0.95% | 0.06% |
| Dec. 19, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share ("Common Stock") | 80069 | $0.90 | 7,937,416.0000 | 129,835,938 | 1.02% | 0.06% |
| Dec. 23, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 6232 | $0.90 | 8,019,148.0000 | 129,835,938 | 0.08% | 0.00% |
| June 30, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 30, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 30, 2025 | Klencke Barbara | Not found | A | Stock Option (Right to Buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 30, 2025 | Nicholson Garry A | Not found | A | Stock Option (Right to Buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 30, 2025 | Woods Keith | Not found | A | Stock Option (Right to Buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 30, 2025 | Dorton Katina | Not found | A | Stock Option (Right to Buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 30, 2025 | Gruia Gabriela | Not found | A | Stock Option (Right to Buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| May 20, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 1200000 | $1.20 | 7,946,141.0000 | 111,990,417 | 17.79% | 1.07% |
| May 19, 2025 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share ("Common Stock") | 1388794 | $1.20 | 6,746,141.0000 | 111,990,417 | 25.92% | 1.24% |
| Jan. 3, 2025 | Louis Chrystal | Chief Medical Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 111,990,417 | 9999.99% | 0.36% |
| Jan. 3, 2025 | Amello Jason | Chief Financial Officer | A | Stock Option (Right to Buy) | 270000 | $0.00 | 270,000.0000 | 111,990,417 | 9999.99% | 0.24% |
| Jan. 3, 2025 | MacBeath Gavin | Chief Executive Officer | A | Stock Option (Right to Buy) | 800000 | $0.00 | 800,000.0000 | 111,990,417 | 9999.99% | 0.71% |
| Jan. 12, 2024 | MacBeath Gavin | Chief Executive Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 65,599,858 | 9999.99% | 0.24% |
| Jan. 12, 2024 | Dworak Leiden | Not found | A | Stock Option (Right to Buy) | 46875 | $0.00 | 46,875.0000 | 65,599,858 | 9999.99% | 0.07% |
| Jan. 3, 2025 | ZDRAVESKI ZORAN | See Remarks | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 111,990,417 | 9999.99% | 0.22% |
| Jan. 12, 2024 | ZDRAVESKI ZORAN | See Remarks | A | Stock Option (Right to Buy) | 52500 | $0.00 | 52,500.0000 | 65,599,858 | 9999.99% | 0.08% |
| Dec. 26, 2024 | Lynx1 Capital Management LP | TenPercentOwner | P | Pre-funded Warrant (right to buy) | 7500000 | $4.00 | 7,500,000.0000 | 118,700,362 | 9999.99% | 6.32% |
| Dec. 13, 2024 | Lynx1 Capital Management LP | TenPercentOwner | P | Common Stock | 100000 | $2.90 | 5,357,347.0000 | 118,700,362 | 1.90% | 0.08% |
| Dec. 12, 2024 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share ("Common Stock") | 31800 | $3.01 | 5,257,347.0000 | 118,700,362 | 0.61% | 0.03% |
| Nov. 15, 2024 | Lynx1 Capital Management LP | TenPercentOwner | P | Common stock, $0.0001 par value per share | 947 | $4.34 | 5,225,547.0000 | 118,700,362 | 0.02% | 0.00% |
| Sept. 23, 2024 | Klencke Barbara | Not found | P | Voting Common Stock | 5000 | $5.29 | 70,000.0000 | 65,599,858 | 7.69% | 0.01% |
| Aug. 23, 2024 | ZDRAVESKI ZORAN | See Remarks | M | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 65,599,858 | 50.00% | 0.04% |
| Aug. 23, 2024 | ZDRAVESKI ZORAN | See Remarks | M | Stock Option (Right to Buy) | 13125 | $0.00 | 21,875.0000 | 65,599,858 | 37.50% | 0.02% |
| Aug. 23, 2024 | ZDRAVESKI ZORAN | See Remarks | M | Stock Option (Right to Buy) | 64166 | $0.00 | 365,834.0000 | 65,599,858 | 14.92% | 0.10% |
| Aug. 23, 2024 | ZDRAVESKI ZORAN | See Remarks | M | Voting Common Stock | 25000 | $3.27 | 92,111.0000 | 65,599,858 | 37.25% | 0.04% |
| Aug. 23, 2024 | ZDRAVESKI ZORAN | See Remarks | M | Voting Common Stock | 13125 | $1.81 | 105,236.0000 | 65,599,858 | 14.25% | 0.02% |
| Aug. 23, 2024 | ZDRAVESKI ZORAN | See Remarks | M | Voting Common Stock | 64166 | $2.49 | 169,402.0000 | 65,599,858 | 60.97% | 0.10% |
| Aug. 23, 2024 | ZDRAVESKI ZORAN | See Remarks | S | Voting Common Stock | 164686 | $5.78 | 4,716.0000 | 65,599,858 | 97.22% | 0.25% |
| Aug. 23, 2024 | ZDRAVESKI ZORAN | See Remarks | M | Stock Option (Right to Buy) | 54895 | $0.00 | 30,105.0000 | 65,599,858 | 64.58% | 0.08% |
| Aug. 23, 2024 | Klencke Barbara | Not found | P | Voting Common Stock | 5000 | $5.69 | 60,000.0000 | 65,599,858 | 9.09% | 0.01% |
| Aug. 26, 2024 | Klencke Barbara | Not found | P | Voting Common Stock | 5000 | $5.53 | 65,000.0000 | 65,599,858 | 8.33% | 0.01% |
| Aug. 23, 2024 | ZDRAVESKI ZORAN | See Remarks | M | Voting Common Stock | 54895 | $4.85 | 67,111.0000 | 65,599,858 | 449.37% | 0.08% |
| June 12, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |
| June 12, 2024 | Klencke Barbara | Not found | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |
| June 12, 2024 | Dorton Katina | Not found | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |
| June 12, 2024 | Woods Keith | Not found | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |
| June 12, 2024 | Nicholson Garry A | Not found | A | Stock Option (Right to Buy) | 23750 | $0.00 | 23,750.0000 | 65,599,858 | 9999.99% | 0.04% |
| June 12, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |
| June 12, 2024 | Nicholson Garry A | Not found | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |
| June 12, 2024 | Gruia Gabriela | Not found | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |
| May 1, 2024 | Louis Chrystal | Chief Medical Officer | A | Stock Option (Right to Buy) | 380000 | $0.00 | 380,000.0000 | 65,599,858 | 9999.99% | 0.58% |
| April 19, 2024 | BAKER BROS. ADVISORS LP | Not found | P | Warrants to purchase Common Stock | 825968 | $7.13 | 4,018,678.0000 | 65,599,858 | 25.87% | 1.26% |
| April 19, 2024 | BAKER BROS. ADVISORS LP | Not found | P | Warrants to purchase Common Stock | 8851451 | $7.13 | 43,158,741.0000 | 65,599,858 | 25.80% | 13.49% |
| April 19, 2024 | Lynx1 Capital Management LP | TenPercentOwner | P | Pre-funded Warrant (right to buy) | 5000000 | $7.13 | 5,000,000.0000 | 65,599,858 | 9999.99% | 7.62% |
| Feb. 1, 2024 | Amello Jason | Chief Financial Officer | A | Stock Option (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 65,599,858 | 9999.99% | 1.14% |